Trial in Progress: A Phase 1b Study of AS-1763, an Oral, Potent and Selective Noncovalent BTK Inhibitor, in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Jain, Nitin, D'Olimpio, James, gillis-Smith, Andew, Lee, Seung Tae, Shah, Nirav N., Pinilla-Ibarz, Javier, Coombs, Catherine C., Barrientos, Jacqueline C., Ma, Shuo, Sawa, Masaaki, Miyamoto, Kyoko, Arimura, Akinori, Gandhi, Varsha, Wierda, William G.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article